Aenova leases SkyePharma plant in a bid to conquer US tablet market
Aenova will take control of SkyePharma tablet production site in a bid to rank in the top European manufacturers.
Aenova will take control of SkyePharma tablet production site in a bid to rank in the top European manufacturers.
The CEO of Covance has warned it will be “very, very difficult” for CROs expanding through M&A to integrate assets, and the process could see clients go elsewhere.
OctoPlus is targeting specialty generics manufacturers it believes can benefit from its controlled release drug delivery technologies.
The pharma biobanking and compound management services sector welcomed its newest member last week with Brooks Automation’s acquisition of Nexus Biosystems.
The Big Pharma CRO strategic partnering model, its impact on drug development and the contract research sector was a hot topic at DIA 2011.
The EDQM has suggested Google Earth as a potential source of GPS co-ordinate data for manufacturing sites that must be supplied in CEP applications under recently introduced requirements.
UPDATE
Pearl IRB and Trafalgar Ethics Board are set to partner in a bid to build a bridge between their US and Canadian review services.
Protein engineering is an untapped method for limiting post-production aggregation that causes immunogenicity, academics say.